object
aim
studi
develop
evalu
score
system
manag
acut
pharyngotonsil
method
conduct
prospect
studi
may
june
patient
acut
pharyngotonsil
evalu
caus
pathogen
assess
clinic
symptom
pharyngotonsillar
find
clinic
score
system
result
total
adult
patient
enrol
studi
streptococcu
pyogen
identifi
thirtyon
virus
also
identifi
pcr
adenoviru
influenza
viru
rs
viru
human
metapneumoviru
number
total
white
blood
cell
level
creactiv
protein
show
signific
posit
correl
clinic
score
p
also
higher
case
pyogen
clinic
score
rapidli
improv
antimicrobi
treatment
moder
case
sever
case
conclus
current
studi
strongli
suggest
clinic
score
system
reflect
diseas
sever
well
would
use
evalu
clinic
cours
decis
make
antimicrobi
treatment
acut
pharyngotonisl
sore
throat
one
commonest
respiratori
symptom
gener
practic
vast
major
adult
present
sore
throat
acut
pharyng
acut
tonsil
also
accompani
acut
pharyng
obviou
typic
appear
tonsil
crypt
stud
purul
materi
purul
exud
cover
palatin
tonsil
manag
acut
pharyngotonsil
import
issu
qualiti
care
infecti
diseas
frequent
outpati
set
case
caus
viral
infect
selflimit
symptomat
treatment
approxim
case
adult
caus
streptococcu
pyogen
pyogen
prescrib
antimicrobi
agent
contrast
rational
manag
pharyngotonsil
antibiot
actual
prescrib
major
adult
patient
approxim
best
way
manag
adult
patient
pharyngotonsil
still
controversi
among
countri
optim
manag
depend
clinic
likelihood
infect
pyogen
rel
import
assign
criteria
avoid
overus
andor
underus
antibiot
prevent
complic
import
develop
clinic
score
system
easi
use
assess
accur
clinic
featur
acut
pharyngotonsil
special
emphasi
infect
pyogen
adult
organ
nationwid
prospect
surveil
studi
group
pharyngotonsil
studi
group
phaton
japan
pharyngotonsil
comparison
clinic
featur
appropri
score
system
also
develop
appli
evalu
sever
clinic
cours
acut
pharyngotonsil
adult
outpati
acut
pharyngotonsil
age
year
old
irrespect
gender
elig
enrol
prospect
studi
diagnost
criteria
acut
pharyngotonsil
includ
sore
throat
histori
fever
erythema
pharyngotonsillar
mucosa
tonsillar
exud
exclus
criteria
includ
case
complic
reduc
antimicrobi
treatment
antibiot
preced
month
pregnanc
immun
defici
includ
immunosuppress
medic
design
studi
prospect
trial
organ
nationwid
studi
group
pharyngotonsil
studi
group
phaton
may
adult
patient
pharyngotonsil
prospect
enrol
studi
sever
clinic
cours
diseas
evalu
clinic
score
system
tabl
swab
tonsillar
crypt
identifi
pathogen
blood
examin
perform
first
visit
day
patient
treat
without
antibiot
accord
sever
ill
briefli
mild
case
treat
oral
antibiot
symptomat
manag
without
antibiot
moder
case
treat
oral
antibiot
sever
case
treat
oral
parenter
antibiot
evalu
relationship
doctor
habit
use
select
antimicrobi
agent
sever
ill
antimicrobi
agent
select
use
physician
decis
inform
consent
approv
institut
review
broad
obtain
patient
time
enrol
studi
assess
sever
clinic
cours
diseas
use
score
system
consist
symptom
pharyngotonsillar
find
tabl
evalu
difficulti
daili
life
sore
throat
fever
symptom
score
erythema
swell
pharyngotonsillar
mucosa
presenc
exud
plug
tonsil
grade
none
mark
sever
diseas
classifi
three
group
accord
total
score
patient
total
score
assign
sever
group
moder
group
mild
group
respect
standard
laboratori
method
perform
identifi
pathogen
bacteria
accord
manual
clinic
microbiolog
edit
briefli
swab
tonsillar
crypt
cultur
sheep
blood
agar
chocol
agar
macconkey
agar
plate
overnight
co
haemophilu
influenza
h
influenza
determin
growth
chocol
blood
agar
plate
catalas
test
requir
x
v
factor
haemophilu
haemolyticu
h
haemolyticu
differenti
h
influenza
haemolysi
blood
agar
plate
streptococcu
pneumonia
pneumonia
identifi
optochin
suscept
bile
solubl
pyogen
confirm
latex
agglutin
commerci
avail
latex
reagen
biomerieux
marci
letoil
franc
bacitracin
suscept
suspect
staphylococcu
aureu
aureu
identifi
use
dnase
test
staphaurex
latex
test
remel
lenexa
usa
growth
bacteria
grade
appli
pcr
identifi
adenoviru
rtpcr
identifi
human
metapneumo
viru
hmpv
influenza
viru
b
respiratori
syncyti
rs
viru
b
swab
tonsillar
crypt
suspend
minimum
essenti
medium
mem
penicillin
streptomycin
nucleic
acid
includ
rna
dna
purifi
use
high
pure
viral
nucleic
acid
purif
kit
roch
basel
switzerland
final
amplifi
product
separ
electrophoresi
agaros
gel
visual
ethidium
bromid
statist
analysi
data
perform
use
nonparametr
test
comparison
two
group
assess
tukeykram
analysi
comparison
clinic
outcom
diseas
assess
wilcoxon
signedrank
test
correl
clinic
score
number
wbc
level
crp
assess
pearson
regress
analysi
statist
test
base
level
signific
pvalu
less
calcul
perform
use
statist
softwar
packag
sa
institut
inc
cari
nc
usa
total
adult
patient
pharyngotonsil
enrol
studi
studi
patient
drop
incomplet
followup
patient
final
evalu
caus
pathogen
clinic
outcom
diseas
male
femal
rang
age
year
old
mean
year
old
acut
pharyng
pain
inflamm
mucosa
pharynx
acut
pharyng
includ
sore
throat
character
sign
erythema
pharyng
mucosa
acut
tonsil
infecti
inflamm
pharyng
tonsil
acut
tonsil
accompani
acut
pharyng
includ
sever
sore
throat
pain
difficult
swallow
fever
chill
character
sign
red
swollen
tonsil
purul
exud
coat
white
pu
characterist
ill
studi
classifi
case
acut
tonsil
case
acut
pharyng
tabl
total
pathogen
bacteria
identifi
total
patient
organ
pyogen
isol
hemolyt
streptococci
isol
h
influenza
isol
h
haemolyticu
isol
aureu
isol
pneumonia
isol
catarrhali
isol
other
isol
tabl
signific
differ
distribut
bacteria
acut
tonsil
pharyng
thirtyon
virus
identifi
pcr
adenoviru
case
influenza
viru
case
rs
viru
case
hmpv
case
tabl
among
case
bacteri
cultur
viru
pcr
perform
bacteria
alon
identifi
case
viru
alon
identifi
case
bacteria
viru
identifi
case
case
neither
bacteria
viru
identifi
sever
diseas
inflammatori
paramet
compar
pathogen
although
pyogen
togeth
hemolyt
streptococci
h
influenza
h
haemolyticu
aureu
pneumonia
catarrhali
frequent
identifi
among
patient
acut
pharyngotonsil
clinic
score
differ
among
fig
hand
number
total
wbc
first
visit
significantli
higher
case
pyogen
case
pathogen
fig
level
crp
significantli
higher
case
pyogen
case
aureu
catarrhali
p
fig
patient
classifi
mild
case
moder
case
sever
case
accord
criteria
clinic
score
ratio
acut
tonsil
pharyng
accord
sever
mild
case
moder
case
sever
case
respect
total
number
wbc
first
visit
show
posit
correl
clinic
score
r
p
fig
mean
ae
sd
wbc
mild
case
moder
case
sever
case
ae
cellsmm
ae
cellsmm
ae
cellsmm
respect
level
crp
first
visit
also
show
posit
correl
clinic
score
r
p
fig
mean
ae
sd
crp
mild
case
moder
case
sever
case
ae
mgdl
ae
mgdl
ae
mgdl
respect
frequenc
isol
pathogen
microorgan
differ
regard
sever
diseas
clinic
outcom
evalu
score
system
accord
sever
diseas
fig
b
mild
case
patient
follow
without
antibiot
improv
score
gradual
wherea
patient
treat
oral
antibiot
ampc
lvfx
cfpn
moder
case
patient
treat
antibiot
patient
treat
ampc
patient
lvfx
patient
sever
case
treat
antibiot
seven
patient
treat
ampc
patient
treat
lvfx
sever
case
patient
treat
parenter
antibiot
among
patient
patient
treat
ctrx
clinic
score
moder
sever
case
significantli
improv
antimicrobi
treatment
p
wide
rang
ill
sore
throat
diagnosi
acut
pharyng
still
troublesom
primari
care
physician
current
studi
defin
caus
pathogen
sever
acut
pharyngo
tonsil
clinic
score
system
adult
patient
acut
pharyngotonsil
report
caus
virus
adenoviru
rhinoviru
corona
viru
parainfluenza
viru
coxacki
viru
influenza
viru
herp
viru
cytomegaloviru
consid
selflimit
studi
frequenc
virus
adult
acut
pharyngotonsil
lower
rather
report
children
appli
pcrrtpcr
identifi
four
import
virus
rs
viru
adenoviru
influenza
viru
hmpv
pharyng
swab
implic
viral
infect
might
low
adult
acut
pharyngotonsil
bacteria
identifi
patient
studi
herein
pyogen
report
import
caus
pathogen
respons
acut
pharyngotonsil
identifi
hemolyt
streptococci
also
frequent
identifi
patient
acut
pharyngotonsil
howev
pathogen
role
group
c
g
streptococci
upper
respiratori
tract
infect
complet
studi
haemophilu
spp
staphylococcu
spp
controversi
isol
pyogen
close
relat
high
valu
inflammatori
paramet
white
blood
cell
creactiv
protein
compar
isol
pathogen
determin
infect
due
pyogen
import
issu
studi
acut
pharyngotonsil
sever
clinic
find
discrimin
valu
distinguish
pyogen
caus
acut
pharyngotonsil
abil
experienc
physician
predict
posit
throat
cultur
pyogen
moder
estim
sensit
specif
rang
respect
attempt
improv
clinic
sensit
specif
investig
develop
clinic
decis
rule
base
constel
physic
sign
symptom
centor
score
reliabl
predictor
estim
likelihood
infect
pyogen
patient
present
sore
throat
score
calcul
determin
mani
follow
four
clinic
featur
present
histori
fever
tonsillar
exud
anterior
cervic
adenopathi
absenc
cough
usual
clinic
set
major
primari
care
physician
prescrib
antimicrobi
agent
painkil
base
sever
ill
although
center
score
use
infer
pyogen
score
valuabl
diagnosi
sever
ill
rapid
antigen
detect
kit
pyogen
use
latex
agglutin
method
also
appli
determin
infect
pyogen
test
show
neg
predict
valu
rel
lower
posit
predict
valu
gener
consensu
neg
rapid
antigen
test
pyogen
confirm
cultur
test
howev
recent
guidelin
suggest
confirm
neg
rapid
antigen
test
result
pyogen
adult
either
necessari
sensit
rapid
antigen
test
rapid
antigen
test
lower
sensit
compar
wellperform
cultur
therefor
import
rapid
identif
pyogen
still
controversi
appli
score
system
base
symptom
clinic
find
diagnos
sever
acut
pharyngotonsil
studi
score
system
reflect
sever
ill
correl
well
number
wbc
level
crp
although
could
found
correl
identif
pyogen
sever
diseas
identif
pyogen
clearli
correl
number
wbc
level
crp
regard
antibiot
treatment
import
discrimin
caus
agent
bacteri
andor
viru
infect
acut
pharyngotonsil
howev
sometim
difficult
discrimin
usual
clinic
set
current
studi
also
design
evalu
correl
among
clinic
paramet
clinic
score
wbc
crp
virus
identifi
patient
correl
identif
virus
number
wbc
level
crp
contrast
number
total
wbc
level
crp
first
visit
significantli
higher
case
pyogen
indicationg
import
pyogen
caus
pathogen
acut
pharyngotonsil
thu
clinic
score
system
togeth
blood
test
could
discrimin
possibl
bacteri
infect
viru
infect
confirm
use
clinic
score
system
evalu
efficaci
antimicrobi
treatment
acut
pharyngotonsil
studi
differ
treatment
outcom
among
variou
age
group
report
group
bhemolyt
streptococcu
requir
antibiot
therapi
studi
mark
reduct
clinic
score
antimicrobi
treatment
sever
moder
case
indic
high
efficaci
ill
higher
sever
hand
mild
case
show
decreas
score
regardless
antimicrobi
treatment
thu
current
studi
strongli
suggest
clinic
score
system
reflect
diseas
sever
well
would
use
evalu
clinic
cours
decis
make
antimicrobi
treatment
acut
pharyngotonisl
